Breaking News Instant updates and real-time market news.

SPPI

Spectrum

$20.36

-0.64 (-3.05%)

16:02
08/09/18
08/09
16:02
08/09/18
16:02

Spectrum backs FY18 revenue view $95M-$115M, consensus $109.45M

  • 04

    Sep

SPPI Spectrum
$20.36

-0.64 (-3.05%)

02/05/18
HCWC
02/05/18
NO CHANGE
Target $33
HCWC
Buy
Spectrum price target raised to $33 from $29 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for Spectrum Pharmaceuticals to $33 after the company's This Advance Phase 3 study met the primary efficacy endpoint of non-inferiority in duration of severe neutropenia between Rolontis and Neulasta. The analyst is encouraged by the positive top-line data and looks forward to the full data set. He continues to believe Rolontis has blockbuster potential and projects revenue of $650M in 2024. White keeps a Buy rating Spectrum.
03/13/18
HCWC
03/13/18
NO CHANGE
Target $33
HCWC
Buy
Spectrum recent weakness a buying opportunity, says H.C. Wainwright
H.C. Wainwright analyst Edward White views the recent pullback in shares of Spectrum Pharmaceuticals as a buying opportunity. The next big clinical update for poziotinib is expected in the second half of 2018, most likely at the World Conference on Lung Cancer, White tells investors in a research note. He believes the recent stock price weakness is due to some investors believing that something is wrong with the study since data will not be at ASCO. The analyst, however, reiterates that he never expected to see data at ASCO. He continues to believe the MD Anderson study is proceeding as expected and keeps a Buy rating on Spectrum with a $33 price target.
04/10/18
RILY
04/10/18
NO CHANGE
Target $26
RILY
Buy
B. Riley FBR says Spectrum likely has one more meeting before poziotinib filing
After Spectrum reported that MD Anderson's Phase 2 study of poziotinib in patients with advanced nonsmall cell lung cancer with EGFR exon 20 mutations has fully enrolled its initial 30- patient cohort and updated on the initial 11 patients, B. Riley FBR analyst David Buck said he expects one more FDA meeting before a likely filing in 2018. He reiterates a Buy rating and $26 price target on Spectrum shares.
06/27/18
RILY
06/27/18
NO CHANGE
Target $26
RILY
Buy
Spectrum takeover report 'plausible,' says B. Riley FBR
Following a report from Bloomberg yesterday that Spectrum Pharmaceuticals is exploring options including a sale of the business amid takeover interest from other drugmakers, B. RIley FBR analyst David Buck told investors in a research note that while he has no confirmation of any takeover interest or sale process, he sees the report as "plausible." Buck, who reiterated a Buy rating, says that he continues to see his $26 per share target based on DCF and 2022E earnings power as "reasonable." Aide from any actual news on a potential transaction or sales process that gets confirmed, he expects further news flow on pipeline drug Rolontis, including a June 29 Spectrum-sponsored conference call and an expected presentation of additional poziotinib data at the World Lung Conference.

TODAY'S FREE FLY STORIES

CORT

Corcept Therapeutics

$15.29

2.31 (17.80%)

14:51
12/11/18
12/11
14:51
12/11/18
14:51
Hot Stocks
Corcept strength attributed to patent issuance »

A spike in shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVV

Valvoline

$20.48

0.33 (1.64%)

14:50
12/11/18
12/11
14:50
12/11/18
14:50
Conference/Events
Valvoline management to meet with Wolfe Research »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

VGK

The Vanguard FTSE Europe ETF

$49.43

0.195 (0.40%)

14:50
12/11/18
12/11
14:50
12/11/18
14:50
Options
Put buyer in Vanguard FTSE Europe ETF opens a defensive position »

Put buyer in Vanguard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEO

American Eagle

$18.95

-0.57 (-2.92%)

14:49
12/11/18
12/11
14:49
12/11/18
14:49
Options
American Eagle options imply 17.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

14:47
12/11/18
12/11
14:47
12/11/18
14:47
Hot Stocks
Breaking Hot Stocks news story  »

Hercules Technology…

TSLA

Tesla

$368.57

3.375 (0.92%)

14:44
12/11/18
12/11
14:44
12/11/18
14:44
Periodicals
Tesla seeks $167 in suit against former employee Tripp, CNBC reports »

Tesla wants over $167M in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IGC

India Globalization Capital

$0.00

(0.00%)

, CANN

General Cannabis

$0.00

(0.00%)

14:43
12/11/18
12/11
14:43
12/11/18
14:43
Periodicals
NY Gov. Cuomo to introduce plan to legalize recreational marijuana, NY Post says »

New York Governor Andrew…

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$31.81

0.82 (2.65%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$12.69

-0.19 (-1.48%)

TLRY

Tilray

$93.40

-3.79 (-3.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.88

0.17 (2.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

QSR

Restaurant Brands

$52.82

-0.97 (-1.80%)

14:40
12/11/18
12/11
14:40
12/11/18
14:40
Options
Puts on the menu at Restaurant Brands International »

Puts on the menu at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CGC

Canopy Growth

$31.78

0.79 (2.55%)

14:39
12/11/18
12/11
14:39
12/11/18
14:39
Technical Analysis
Technical Take: Canopy Growth pops in later afternoon trading »

The shares have spiked in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CSCO

Cisco

$46.72

-0.14 (-0.30%)

, INTC

Intel

$47.16

-0.05 (-0.11%)

14:31
12/11/18
12/11
14:31
12/11/18
14:31
Periodicals
Cisco in talks to acquire chip company Luxtera, Bloomberg reports »

Cisco Systems (CSCO) is…

CSCO

Cisco

$46.72

-0.14 (-0.30%)

INTC

Intel

$47.16

-0.05 (-0.11%)

AVGO

Broadcom

$244.97

5.76 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

DUK

Duke Energy

$90.52

-0.03 (-0.03%)

14:18
12/11/18
12/11
14:18
12/11/18
14:18
Hot Stocks
Duke says 45,000 customers in Carolinas remain without power after storm »

Duke Energy said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/11/18
12/11
14:17
12/11/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBTYA

Liberty Global

$22.82

-0.84 (-3.55%)

, VOD

Vodafone

$20.08

-0.055 (-0.27%)

14:16
12/11/18
12/11
14:16
12/11/18
14:16
Hot Stocks
Liberty Global says 'always anticipated' second phase review from EC »

The European Commission…

LBTYA

Liberty Global

$22.82

-0.84 (-3.55%)

VOD

Vodafone

$20.08

-0.055 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/11/18
12/11
14:16
12/11/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$147.66

-4.32 (-2.84%)

, SFTBF

SoftBank

$0.00

(0.00%)

14:13
12/11/18
12/11
14:13
12/11/18
14:13
Hot Stocks
Nvidia near lows as SoftBank said to plan sale of stake »

Shares of Nvidia (NVDA)…

NVDA

Nvidia

$147.66

-4.32 (-2.84%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

NVDA

Nvidia

$147.60

-4.38 (-2.88%)

, SFTBF

SoftBank

$0.00

(0.00%)

14:11
12/11/18
12/11
14:11
12/11/18
14:11
Periodicals
Breaking Periodicals news story on Nvidia, SoftBank »

SoftBank planning sale of…

NVDA

Nvidia

$147.60

-4.38 (-2.88%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

CSCO

Cisco

$46.81

-0.05 (-0.11%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Periodicals
Breaking Periodicals news story on Cisco »

Cisco in talks to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 10

    Jan

CORT

Corcept Therapeutics

$12.66

-0.32 (-2.47%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Hot Stocks
Corcept Therapeutics spikes in afternoon trading, jump 16% »

Corcept is up $2.04, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTV

Aptiv

$66.34

1.01 (1.55%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Hot Stocks
Aptiv CEO Kevin Clark purchases 11,310 shares of company stock »

Aptiv CEO Kevin Clark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$42.08

-1.14 (-2.64%)

14:10
12/11/18
12/11
14:10
12/11/18
14:10
Options
Second day of short-term put buying in First Solar ahead of a company event »

Second day of short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BGG

Briggs & Stratton

$13.32

-0.32 (-2.35%)

14:05
12/11/18
12/11
14:05
12/11/18
14:05
Hot Stocks
Briggs & Stratton unit announces facility expansion for job site products »

Allmand Bros, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$66.32

0.42 (0.64%)

14:05
12/11/18
12/11
14:05
12/11/18
14:05
Options
XPO Logistics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$81.53

-0.93 (-1.13%)

, MCO

Moody's

$145.15

-0.75 (-0.51%)

13:55
12/11/18
12/11
13:55
12/11/18
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Financial…

COF

Capital One

$81.53

-0.93 (-1.13%)

MCO

Moody's

$145.15

-0.75 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

GE

General Electric

$6.78

-0.145 (-2.10%)

13:50
12/11/18
12/11
13:50
12/11/18
13:50
Options
Put spread in General Electric may adjust downside position »

Put spread in General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$82.62

1.19 (1.46%)

13:47
12/11/18
12/11
13:47
12/11/18
13:47
Upgrade
Kadant rating change  »

Kadant upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 20

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.